Senescence marker protein-30 deficiency impairs angiogenesis under ischemia

Free Radical Biology & Medicine
Hiroyuki YamauchiYasuchika Takeishi

Abstract

Aging decreases collateral-dependent flow recovery following acute arterial obstruction. However, the mechanisms are partially understood, therefore critical management has been lacked in clinical setting. Senescence marker protein-30 (SMP30) is a novel aging marker, which is assumed to act as an anti-aging factor in various organs. Therefore, we studied the effect of SMP30 on ischemia-induced collateral growth in SMP30 knockout (KO) mice, young and old C57BL/6 mice. The SMP30 expression in gastrocnemius tissue was decreased in old mice compared to that of young mice. The recovery of cutaneous blood flow in hind limb after femoral artery ligation and tissue capillary density recoveries were suppressed in SMP30 KO and old mice compared to those in young mice. Nitric oxide generation induced by l-arginine and GSH/GSSG in aorta of SMP30 KO and old mice were lower than those in young mice. The levels of NADPH oxidase activity and superoxide production in the ischemic tissue were higher in SMP30 KO and old mice than in young mice. The phosphorylated eNOS and Akt levels and VEGF levels in ischemic muscle were lower in SMP30 KO and old mice than in young mice. Deficiency of SMP30 exacerbates oxidative stress related to NADPH oxidase a...Continue Reading

References

Sep 1, 1994·Journal of Gerontology·L T CooperV J Dzau
Jan 1, 1997·Annals of Surgery·B G HarbrechtT R Billiar
Jun 17, 1998·The Journal of Clinical Investigation·T MuroharaJ M Isner
Jan 13, 1999·Circulation·A RivardJ M Isner
Mar 25, 1999·American Journal of Hypertension·C J CharlesM G Nicholls
Sep 14, 2000·Proceedings of the National Academy of Sciences of the United States of America·M L BrinesA Cerami
Jun 14, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Francis A SylvesterJulian H Lombard
Oct 11, 2002·Free Radical Biology & Medicine·Nilanjana Maulik, Dipak K Das
Feb 21, 2004·Biochemical and Biophysical Research Communications·Akihito IshigamiNaoki Maruyama
Dec 13, 2005·Experimental Cell Research·Masabumi Shibuya, Lena Claesson-Welsh
Feb 28, 2006·Mechanisms of Ageing and Development·Tae Gen SonJaewon Lee
May 27, 2006·American Journal of Respiratory and Critical Care Medicine·Tadashi SatoAkihito Ishigami
Jun 30, 2006·Journal of Molecular and Cellular Cardiology·Sophie Elise MichaudAlain Rivard
Jul 18, 2006·European Journal of Pharmacology·Federica LodiFrancisco Perez-Vizcaino
Apr 12, 2007·Physiological Genomics·Dan ChalothornJames E Faber
Jul 21, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jonas LefèvreAlain Rivard
Jul 31, 2007·Current Opinion in Pharmacology·Molly M Gallogly, John J Mieyal
Oct 30, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Shu-ichi SaitohWilliam M Chilian
Jun 12, 2008·Free Radical Biology & Medicine·Christine C Winterbourn, Mark B Hampton
Aug 23, 2008·Journal of Applied Physiology·Lakshmi SanthanamDan E Berkowitz
Dec 19, 2009·Circulation·UNKNOWN WRITING GROUP MEMBERSUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Dec 7, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Toshiaki MishimaMasataka Majima
Feb 2, 2011·Proceedings of the National Academy of Sciences of the United States of America·Yao LuJincai Luo
Jun 14, 2012·The Journal of Biological Chemistry·Ke-Jie YinY Eugene Chen
Jun 27, 2012·Circulation·Stephen E EpsteinMary Susan Burnett
Jan 17, 2013·Antioxidants & Redox Signaling·Shinya YamadaYasuchika Takeishi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.